| Active substance |
Diclofenac Sodium |
| Also known as |
Diclofenac sodium, Diclofenac potassium |
| Blood pressure |
Can cause an increase in blood pressure in susceptible individuals |
| Chemical name |
2-[(2,6-dichlorophenyl)amino]benzeneacetic acid |
| Dosage (medical) |
50 mg to 150 mg daily, depending on the severity of the condition |
| Dosage (sports) |
Not typically prescribed for sports-related use |
| Effects |
Anti-inflammatory, analgesic, antipyretic |
| FORM |
50 g x 20 mg/g |
| Formula |
C14H11Cl2NO2 |
| Half-life |
1.2 to 2 hours |
| Hepatotoxicity |
Rare, but potential for liver damage in long-term or high-dose use |
| Lab Test |
Not commonly required for monitoring |
| Main action |
Reduces inflammation and pain |
| Side effects |
Gastrointestinal problems, renal impairment, cardiovascular risk, allergic reactions |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Substance class |
Nonsteroidal anti-inflammatory drug (NSAID) |
| Trade name |
Voltaren, Cataflam, among others |
| Use in sports |
Not commonly used, potential for misuse as pain relief to mask injury |
| Water Retention |
Minimal |
| Manufacturer |
Teva Pharmaceutical |
